OOIR: Observatory of International Research

Papers

(The H4-Index of npj Precision Oncology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Defective homologous recombination and genomic instability predict increased responsiveness to carbon ion radiotherapy in pancreatic cancer	168
Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat	126
Pan-cancer analysis uncovered the prognostic and therapeutic value of disulfidptosis	114
Single cell analysis revealed SFRP2 cancer associated fibroblasts drive tumorigenesis in head and neck squamous cell carcinoma	92
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes	87
Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma	78
New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology	73
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma	72
Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria	70
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer	69
Immunological subtyping of salivary gland cancer identifies histological origin-specific tumor immune microenvironment	68
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy	65
An automatic pipeline for temporal monitoring of radiotherapy-induced toxicities in head and neck cancer patients	63
Barriers and opportunities in pancreatic cancer immunotherapy	60
Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis	58
Copy-number alterations in cell-free DNA can be transient or harbingers of clonal hematopoiesis	56
High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer	55
Author Correction: An automated deep learning pipeline for EMVI classification and response prediction of rectal cancer using baseline MRI: a multi-centre study	54
Comparison of DNA methylation based classification models for precision diagnostics of central nervous system tumors	49
Development and validation of a gene expression-based Breast Cancer Purity Score	48
Deep learning for endometrial cancer subtyping and predicting tumor mutational burden from histopathological slides	47
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis	46
Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolution	45
Towards precision radiation oncology: endocrine therapy response as a biomarker for personalization of breast radiotherapy	44
HRD effects on first-line adjuvant chemotherapy and PARPi maintenance therapy in Chinese ovarian cancer patients	44

Analyses of canine cancer mutations and treatment outcomes using real-world clinico-genomics data of 2119 dogs	43
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment	43
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)	42
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia	42
Biallelic EPCAM deletions induce tissue-specific DNA repair deficiency and cancer predisposition	38
Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies	38
Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns	38
Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma	36
Precision medicine: affording the successes of science	36
Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1	36
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression	36